ArticleClinical kidney journal2026

Real-world management of tuberous sclerosis complex-associated renal angiomyolipomas: the impact of mTOR inhibitors.

Nicolas Gemander et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.